← Open Payments lookup

IVEY WALKER: Open Payments

NPI 1215678487 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,617 in 44 payments from 18 companies in 2025. Trend: 2023 $1,512 · 2024 $1,248 · 2025 $2,617

Food & beverage: $1,419Long term medical supply or device loan: $1,196Speaker / faculty: $2
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation13$1,230
Daiichi Sankyo Inc.6$246
Janssen Biotech, Inc.2$215
Myriad Genetic Laboratories, Inc.3$215
PFIZER INC.2$140
AstraZeneca Pharmaceuticals LP1$114
Stemline Therapeutics Inc.1$109
Lilly USA, LLC2$56
Karyopharm Therapeutics Inc.2$48
Gilead Sciences, Inc.2$43

Products named: KISQALI, Enhertu, RYBREVANT, MYRISK, BRAFTOVI, ELZONRIS, VERZENIO, XPOVIO.

Industry payments across TX — which companies pay providers there.